Laura E. Rothuizen

1.1k total citations
38 papers, 733 citations indexed

About

Laura E. Rothuizen is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Laura E. Rothuizen has authored 38 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 9 papers in Pediatrics, Perinatology and Child Health and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Laura E. Rothuizen's work include Pregnancy and Medication Impact (8 papers), Epilepsy research and treatment (5 papers) and Forensic Toxicology and Drug Analysis (4 papers). Laura E. Rothuizen is often cited by papers focused on Pregnancy and Medication Impact (8 papers), Epilepsy research and treatment (5 papers) and Forensic Toxicology and Drug Analysis (4 papers). Laura E. Rothuizen collaborates with scholars based in Switzerland, France and United States. Laura E. Rothuizen's co-authors include Thierry Buclin, Jérôme Biollaz, Laurent A. Décosterd, M. Appenzeller, Marc Augsburger, Annick Ménétrey, Patrice Mangin, Bernard Favrat, Christian Giroud and Georgios Eleftheriou and has published in prestigious journals such as Neurology, Scientific Reports and Clinical Pharmacology & Therapeutics.

In The Last Decade

Laura E. Rothuizen

34 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura E. Rothuizen Switzerland 12 171 171 126 123 93 38 733
Gillian Shepherd United States 14 751 4.4× 81 0.5× 57 0.5× 74 0.6× 109 1.2× 26 1.4k
Zoubir Djerada France 17 77 0.5× 59 0.3× 57 0.5× 51 0.4× 146 1.6× 91 916
Efisio Cossu Italy 19 73 0.4× 90 0.5× 46 0.4× 55 0.4× 175 1.9× 53 1.1k
Bastard Jp France 7 61 0.4× 83 0.5× 44 0.3× 82 0.7× 120 1.3× 11 1.1k
Bojan Lalovic United States 11 73 0.4× 143 0.8× 239 1.9× 235 1.9× 17 0.2× 23 992
Angela Koverech Italy 15 42 0.2× 51 0.3× 46 0.4× 51 0.4× 57 0.6× 29 944
Athanasios Raptis Greece 15 51 0.3× 42 0.2× 36 0.3× 64 0.5× 116 1.2× 39 1.0k
Jen‐Huai Chiang Taiwan 18 95 0.6× 37 0.2× 20 0.2× 91 0.7× 48 0.5× 59 912
Xiaoyan Yang China 13 113 0.7× 32 0.2× 54 0.4× 34 0.3× 66 0.7× 38 741
Jang Won Son South Korea 17 85 0.5× 131 0.8× 28 0.2× 30 0.2× 118 1.3× 53 940

Countries citing papers authored by Laura E. Rothuizen

Since Specialization
Citations

This map shows the geographic impact of Laura E. Rothuizen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Rothuizen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Rothuizen more than expected).

Fields of papers citing papers by Laura E. Rothuizen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Rothuizen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Rothuizen. The network helps show where Laura E. Rothuizen may publish in the future.

Co-authorship network of co-authors of Laura E. Rothuizen

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Rothuizen. A scholar is included among the top collaborators of Laura E. Rothuizen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Rothuizen. Laura E. Rothuizen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haefliger, David, Leonardo Mina, Monia Guidi, et al.. (2025). Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysis. Journal of Antimicrobial Chemotherapy. 80(3). 840–847. 4 indexed citations
2.
Bertin, Stéphane, David Haefliger, Antoine Schneider, et al.. (2025). Effects of Extracorporeal Membrane Oxygenation Circuits on Drug Sequestration: A Review of Ex Vivo Experiments. Journal of Clinical Medicine. 14(22). 8060–8060.
3.
Buettcher, Michael, Jörg Huwyler, John van den Anker, et al.. (2024). Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg. Pharmaceutics. 16(9). 1186–1186.
4.
Audran, R, Haïthem Chtioui, Anne‐Christine Thierry, et al.. (2024). Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study. Scientific Reports. 14(1). 12872–12872. 1 indexed citations
5.
Rothuizen, Laura E., et al.. (2022). Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines. International Journal of Audiology. 62(6). 587–591. 17 indexed citations
6.
Dao, Kim, Vincent Jullien, Pascal André, et al.. (2022). An innovative ethosuximide granule formulation designed for pediatric use: Comparative pharmacokinetics, safety, tolerability, and palatability profile versus reference syrup. Pharmacology Research & Perspectives. 11(1). e01032–e01032. 3 indexed citations
7.
André, Pascal, Kim Dao, Laura E. Rothuizen, et al.. (2022). Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!. Frontiers in Pediatrics. 9. 768438–768438. 10 indexed citations
8.
Chtioui, Haïthem, et al.. (2022). Pharmacovigilance. Vaccins à ARNm contre le Covid-19 : le point sur les effets indésirables. Revue Médicale Suisse. 18(767). 190–197. 2 indexed citations
9.
Buclin, Thierry, Laura E. Rothuizen, & Françoise Livio. (2021). Médicaments, sexe et genre. Revue Médicale Suisse. 17(7442). 1262–1264.
10.
Dubois, Julie, Pierre‐Yves Rodondi, Khalil Zaman, et al.. (2019). Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre. Scientific Reports. 9(1). 5078–5078. 84 indexed citations
11.
Weber‐Schoendorfer, Corinna, Marc Oppermann, Evelin Wacker, et al.. (2015). Pregnancy outcome after TNF‐α inhibitor therapy during the first trimester: a prospective multicentre cohort study. British Journal of Clinical Pharmacology. 80(4). 727–739. 105 indexed citations
12.
Winterfeld, Ursula, Verena Gotta, Laura E. Rothuizen, et al.. (2014). Antiepileptika bei Frauen im gebärfähigen Alter und in der Schwangerschaft. Der Nervenarzt. 85(6). 738–746. 1 indexed citations
13.
Nový, Jan, Laura E. Rothuizen, Thierry Buclin, & Andrea O. Rossetti. (2014). Perampanel: A Significant Liver Enzyme Inducer in Some Patients?. European Neurology. 72(3-4). 213–216. 5 indexed citations
14.
Renard, Delphine, et al.. (2013). PP017—Spectrum of ocular digoxin toxicity in the elderly: A case report. Clinical Therapeutics. 35(8). e22–e23.
15.
Winterfeld, Ursula, Alice Panchaud, Paul Merlob, et al.. (2011). Pregnancy Outcome Following Maternal Exposure To Statins: A Multicenter Prospective Study. IRIS. 1 indexed citations
16.
Livio, Françoise, et al.. (2010). Pharmacovigilance update [Pharmacovigilance update]. SERVAL (Université de Lausanne). 1 indexed citations
17.
Giroud, C., Marc Augsburger, Bernard Favrat, et al.. (2006). Effets du cannabis oral et du dronabinol sur la capacité à conduire. Annales Pharmaceutiques Françaises. 64(3). 161–172. 8 indexed citations
18.
19.
Favrat, Bernard, Annick Ménétrey, Marc Augsburger, et al.. (2005). Two cases of "cannabis acute psychosis" following the administration of oral cannabis. BMC Psychiatry. 5(1). 17–17. 64 indexed citations
20.
Rothuizen, Laura E., et al.. (1998). Pharmacodynamic response to interferon beta-1a administered subcutaneously one-a-week or three-times-a-week, over one month. Clinical Pharmacology & Therapeutics. 63(2). 200. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gillian Shepherd Breakdown of academic impact, for papers by Zoubir Djerada Breakdown of academic impact, for papers by Efisio Cossu Breakdown of academic impact, for papers by Bastard Jp Breakdown of academic impact, for papers by Bojan Lalovic Breakdown of academic impact, for papers by Angela Koverech Breakdown of academic impact, for papers by Athanasios Raptis Breakdown of academic impact, for papers by Jen‐Huai Chiang Breakdown of academic impact, for papers by Xiaoyan Yang Breakdown of academic impact, for papers by Jang Won Son
Rankless by CCL
2026